ML21096A015: Difference between revisions
StriderTol (talk | contribs) (StriderTol Bot insert) |
StriderTol (talk | contribs) (StriderTol Bot change) |
(3 intermediate revisions by the same user not shown) | |
(No difference)
|
Latest revision as of 18:05, 19 January 2022
ML21096A015 | |
Person / Time | |
---|---|
Issue date: | 05/10/2021 |
From: | Stewart Schneider NRC/NMSS/DREFS/RRPB |
To: | |
Schneider, Stewart | |
References | |
10 CFR Part 26, 20210348, NRC-2009-0225, RIN 3150-AI67 | |
Download: ML21096A015 (6) | |
Text
U.S. Nuclear Regulatory Commission Public Meeting Summary May 10, 2021
Title:
Fitness for Duty Drug Testing Requirements Final Rule (Cumulative Effects of Regulation)
Meeting Identifier: 20210348 Date of Meeting: April 13, 2021 Location: Webinar Type of Meeting: Information Meeting with a Question and Answer Session.
Purpose of the Meeting:
To discuss the proposed effective date of the draft final rule for Fitness for Duty Drug Testing Requirements and to provide a summary of substantive public comments received on the proposed rule resulting in changes to the final rule.
This meeting also provided an opportunity for the NRC staff to obtain feedback from members of the public on the effective date of the final rule as it pertains to the cumulative effects of regulation.
General Details:
The NRC conducted a public meeting scheduled from 10:00 a.m. - 11:00 a.m. eastern standard time that ran approximately 1 hour1.157407e-5 days <br />2.777778e-4 hours <br />1.653439e-6 weeks <br />3.805e-7 months <br />. The meeting was attended by 93 individuals, including 19 NRC staff and 74 members of the public. All attendees participated via WebEx and teleconference. Meeting participants included nuclear power reactor licensees (e.g., Energy Harbor, Exelon, Duke Energy), representatives from the nuclear industry (e.g., Nuclear Energy Institute), other stakeholders (e.g., Curtiss-Wright, Morgan Lewis & Bockius LLP), and a private citizen. The meeting was transcribed, and the transcript is available in the NRCs Agencywide Document Access and Management System (ADAMS) under Accession No. ML21096A011, and at Regulations.gov under Docket No. NRC-2009-0225. A list of attendees is provided as an attachment to this meeting summary.
Summary of NRC Presentation:
The meeting began with an NRC presentation on the rulemaking background and final rule schedule. The NRC noted that 22 public comment submissions were received on the proposed rule. Next the NRC explained the concept of cumulative effects of regulation (CER) and its relationship to informing the implementation schedule for licensees to comply with the final rule requirements. The NRC proposed a 60-day compliance schedule based on CER and the substantive changes to the final rule.
The NRC summarized key proposed rule revisions on the drug testing panel, subversion attempt detection, and shy-bladder hydration process. The NRC discussed substantive public comments received in response to questions included in the proposed rule notice (84 FR 48750; September 16, 2019) on new test analytes (2017 HHS Guidelines) and directly observed specimen collections. The NRC explained final rule changes in response to the two questions. Specifically, expanding the drug testing panel to include hydrocodone, hydromorphone, oxycodone, and oxymorphone; and providing the option to collect an oral fluid specimen instead of a urine specimen under direct observation conditions.
The NRC discussed two public comments received on a question in the proposed rule notice on the 60-day effective date to comply with the final rule changes. One commenter requested a period of 120 days to comply with the revised requirements and the other requested 1 year.
The NRC explained that the 60-day implementation schedule was proposed because the rule changes were not expected to result in CER impacts on effected licensees and other entities.
The NRC provided three reasons for this decision: 1) no other pending 10 CFR Part 26 regulatory actions exist that would impact the site professionals responsible for implementing the rule requirements, 2) changes to the fitness for duty (FFD) policy, procedures, contracts, and training are minimal, and 3) implementation guidance will be issued with the rule. This completed the NRCs discussion on the rulemaking activity.
The NRC then opened the meeting for feedback and questions. The meeting concluded with a description of how to find information for this rulemaking at regulations.gov and use of the NRC public meeting feedback form.
The meeting transcript, which provides the complete meeting discussions, is available in ADAMS under Accession No. ML21096A011. Also, the NRCs presentation slides are available in ADAMS under Accession No. ML21096A010.
Public Participation Themes:
Feedback was received from one public participant, the Nuclear Energy Institute (NEI), during the discussion and question segment of the meeting. NEI was supportive of the proposed new rule changes and the resulting increased effectiveness of the FFD Program, but stated that a one-year implementation period was needed to comply with the final rule changes. The NEI representatives concern was that the 60-day implementation period did not provide sufficient time for management and staff to handle the significant operational challenges posed prior to, during, and after Spring and Fall outages, updates to the industrys training system (NANTeL),
licensee information technology system changes, and the ongoing impacts of COVID and remote work status of staff. This and the NRC response are captured in the public meeting transcript.
Action Items/Next Steps:
- There were no action items as a result of the public meeting.
- Final rule will be provided to the Commission by early fall 2021.
Additional Information:
- Meeting notice and agenda: ADAMS Accession No. ML21084A074
- NRC staff presentation: ADAMS Accession No. ML21096A010
- Transcript: ADAMS Accession No. ML21096A011
- Meeting Summary: ADAMS Accession No. ML21096A015
FITNESS FOR DUTY DRUG TESTING REQUIREMENTS FINAL RULE (CUMULATIVE EFFECTS OF REGULATION PUBLIC MEETING HELD ON 04/13/2021 CATEGORY: INFORMATION MEETING WITH A QUESTION AND ANSWER SESSION LIST OF ATTENDEES No. First Name Last Name Affiliation 1 Howard Benowitz NRC 2 Helen Chang NRC 3 Christian Cowdrey NRC 4 Kevin Coyne NRC 5 David Desaulniers NRC 6 Brian Green NRC 7 Paul Harris NRC 8 Glenna Lappert NRC 9 Tim Mossman NRC 10 James O'Driscoll NRC 11 Kevin Ramsey NRC 12 Stewart Schneider NRC 13 Fred Schofer NRC 14 Soly Soto Lugo NRC 15 Gregory Suber NRC 16 Brian Thomas NRC 17 Justin Vazquez NRC 18 Ilka Verrius NRC 19 Brian Zaleski NRC 20 Amy Findley Ameren Missouri 21 Mike Haglund Calloway Energy Center 22 Shane Mecaskey Comanche Peak Nuclear Power Plant 23 Latham Meiers Comanche Peak Nuclear Power Plant 24 Richard Swanson Comanche Peak Nuclear Power Plant 25 Jeff Schwarting Cooper Nuclear Station 26 Anna Raleigh Curtiss-Wright 27 Zack Schwenk Curtiss-Wright 28 Patrick Anhalt Dominion Energy 29 Richard Hanson Dominion Energy 30 Bobby Hote Dominion Energy 31 Adam Murphy Dominion Energy
FITNESS FOR DUTY DRUG TESTING REQUIREMENTS FINAL RULE (CUMULATIVE EFFECTS OF REGULATION PUBLIC MEETING HELD ON 04/13/2021 CATEGORY: INFORMATION MEETING WITH A QUESTION AND ANSWER SESSION LIST OF ATTENDEES No. First Name Last Name Affiliation 32 Cynthia Bomyea DTE Energy 33 Leah Paul DTE Energy 34 Cara Davis Duke Energy (Medical One Medical Group) 35 Terry King Duke Energy 36 Theodore (Teddy) Reed Duke Energy 37 Wendy Wilder Duke Energy 38 John Coleman Endevor 39 Alexander Ellis Energy Harbor 40 Vincent Forbus Energy Harbor 41 Maureen Gulliford Energy Harbor 42 Bryan Jackway Energy Harbor 43 Norbert Schutte Energy Harbor 44 Brenda Thorbahn Energy Harbor (Davis Besse) 45 Vanessa Perez Energy Northwest 46 Steven Chambliss Entergy Nuclear (Grand Gulf) 47 Stephanie Colburn Entergy Nuclear 48 Matthew Deignan Entergy Nuclear (Riverbend Station) 49 Kelly Pettus Entergy Nuclear 50 Chris Pond Entergy Nuclear 51 Karen Murphy Entergy Nuclear (Grand Gulf) 52 Scott Summers Entergy Nuclear (Palisades) 53 Jerry Woods Entergy Nuclear 54 Delores Adams Exelon 55 Andy Anderson Exelon 56 Stephen Henry Exelon 57 Mary Scarce Exelon 58 Tim Chapin INPO 59 Ben Schaffer INPO 60 Latham Meier Luminant 61 Richard Swanson Luminant 62 Lewis Csedrik Morgan Lewis
FITNESS FOR DUTY DRUG TESTING REQUIREMENTS FINAL RULE (CUMULATIVE EFFECTS OF REGULATION PUBLIC MEETING HELD ON 04/13/2021 CATEGORY: INFORMATION MEETING WITH A QUESTION AND ANSWER SESSION LIST OF ATTENDEES No. First Name Last Name Affiliation 63 Ariel Braunstein Morgan Lewis & Bockius LLP 64 Misty Thomas n/a 65 David Vandercamp NE Public Power District 66 Joseph Garry Neal R Gross & Co., Inc. (Court Reporter) 67 William Gross NEI 68 Johnny Rogers NEI 69 Don Popp NextEra Energy 70 Anonymous Anonymous NuScale Power 71 Kevin Deyette NuScale Power, LLC 72 Theresa Jones Palo Verde 73 Don Townsend PG&E 74 Cajya Darling PSEG 75 Elizabeth Fox PSEG 76 Tina Gregory PSEG 77 Trina Washington PSEG 78 John Coleman Software Vendor 79 Leslie Lathrop Southern California Edison Co.
80 Cheree Montgomery Southern Nuclear 81 Sara Ledwig STP Nuclear-South Texas Project 82 Clair Manges Susquehanna Steam Electric Plant 83 Michele Hockenberry Talen Energy 84 Mike Palmer Talen Energy (Susquehanna Nuclear) 85 Paul Zaffuts The Zaffuts Group 86 Bryan Henderson TVA 87 Patrick Asendorf TVA 88 Michael Covert Vistra 89 Sonya Jones Wolf Creek 90 Pam Black Wolf Creek 91 Dana Hickey Xcel Energy 92 David Gerads Xcel Energy